The primary objective for this domain is to determine if early oral switch is non-inferior to continued intravenous (IV) treatment for PSSA, MSSA and MRSA bacteraemia.
SNAP Trial Learning Resources
Learn more about why we’re studying treatments for S. aureus bloodstream infections in the SNAP trial.
Watch this video to learn more about the SNAP Antibiotic Backbone Domain.
